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Background: Deletions and duplications of the PAFAH1B1 and YWHAE genes in 17p13.3 are associated with
different clinical phenotypes. In particular, deletion of PAFAH1B1 causes isolated lissencephaly while deletions
involving both PAFAH1B1 and YWHAE cause Miller-Dieker syndrome. Isolated duplications of PAFAH1B1 have
been associated with mild developmental delay and hypotonia, while isolated duplications of YWHAE have been
associated with autism. In particular, different dysmorphic features associated with PAFAH1B1 or YWHAE duplication
have suggested the need to classify the patient clinical features in two groups according to which gene is
involved in the chromosomal duplication.
Methods: We analyze the proband and his family by classical cytogenetic and array-CGH analyses. The putative
rearrangement was confirmed by fluorescence in situ hybridization.
Results: We have identified a family segregating a 17p13.3 duplication extending 329.5 kilobases by FISH and
array-CGH involving the YWHAE gene, but not PAFAH1B1, affected by a mild dysmorphic phenotype with associated
autism and mental retardation. We propose that BHLHA9, YWHAE, and CRK genes contribute to the phenotype of
our patient. The small chromosomal duplication was inherited from his mother who was affected by a bipolar and
borderline disorder and was alcohol addicted.
Conclusions: We report an additional familial case of small 17p13.3 chromosomal duplication including only
BHLHA9, YWHAE, and CRK genes. Our observation and further cases with similar microduplications are expected to
be diagnosed, and will help better characterise the clinical spectrum of phenotypes associated with 17p13.3
microduplications.
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The short arm of chromosome 17 is particularly prone to
submicroscopic rearrangements due to the presence of
high density low copy repeats (LCRs). The proximal re-
gion of the short arm harbors a number of syndromes
such as CMT1A (Charcot–Marie–Tooth syndrome type
1A), HNPP (hereditary neuropathy with liability to* Correspondence: giorgio.gimelli@gmail.com
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reproduction in any medium, provided the orpressure palsies), Smith–Magenis syndrome, and Potocki–
Lupski syndrome. It is known that heterozygous 17p13.3
deletions, including PAFAH1B1 (MIM 601545) and
YWHAE (MIM 605066) genes, cause two clinically distinct
disorders: LSI (isolated lissencephaly) or MDS (Miller-Die-
ker syndrome), depending on the size of the deletion [1].
Recently, new genomic disorders have been identified in
the MDS locus. To date, twenty-two microdeletions [2-6]
and sixteen microduplications [5,7-9] overlapping the
MDS critical region have been described in unrelated indi-
viduals. All these submicroscopic rearrangements aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[5] proposed to divide 17p13.3 microduplications in
two different classes: class I microduplications involving
YWHAE but not PAFAH1B1 showing a phenotype
characterized by learning difficulties and/or autism with
or without other congenital abnormalities; class II micro-
duplications always harboring PAFAH1B1 that may also
include the genomic region encompassing the CRK and
YWHAE genes, which are associated with developmental
delay, psychomotor delay, and associated hypotonia.
Here we report on a 7-year-old boy and his mother
presenting a novel class I 17p13.3 microduplication
measuring about 329.5 Kb in length and involving only
seven genes, including YWHAE, CRK, and BHLHA9.
Methods
Case presentation
The proband, a 7-year-old boy with a Caucasian ances-
try, is the third child of non-consanguineous parents.
The mother presents antisocial behaviour and bipolar
disorder, she was HIV positive and alcohol addicted. The
father was drug addicted, but was not available for
array-CGH analysis. One sister was reported as healthy
while a second one was reported to manifest behavioural
problems and aggressiveness. Both sisters were not avail-
able for testing because they were living apart from their
brother. The proband is currently legally in care of his
maternal grandparents, but lives with his maternal uncle.
His maternal grandmother was affected by depression
and has been recently diagnosed as having bilateral
breast cancer. His maternal grandmother and maternal
uncle were available for array-CGH analysis (Figure 1A).
The child was born at 37 weeks of gestation by caesar-
ean section after a pregnancy complicated by gestosis.
His birthweight was 3350 g, length and head circumfer-
ence were not reported. APGAR score was 8 and 9 at
first and fifth minute. At eight months of age, because of
motor delay and mild lower limb hypertonia, transfonta-
nellar ultrasound was performed and it appeared nor-
mal. The patient underwent physiotherapy treatment for
one year with partial improvement. He was able to
walk at 18 months of age and uttered his first words at
2 years of age. Moreover, poor social relationships and
motor stereotypes were noticed. He presented appropri-
ate growth. At five years five months of age, his neuro-
logical examination was characterized by clumsiness
without obvious focal signs. A moderate mental retard-
ation was noticed: the General Developmental Quotient
assessed according to the Griffiths Mental Development
Scale was 46. Behavioural and neuropsychological eva-
luations revealed an autism defined as a pervasive devel-
opmental disorder not otherwise specified (PDD-NOS)
with social interaction and communication impairment,
motor stereotypes, persistent behaviours, and attentiondeficit. At seven years five months of age, weight was
22.8 kg (50th centile), height 123 cm (75th centile), and
head circumference 52.5 cm (25th-50th centile). At phys-
ical examination, the child presented thick linearized
eyebrows, myopia with upslanting eyes, squared
upturned tip of the nose, pointed chin, large and low-set
ears. His hands were short and stubby with low-set
thumbs (Figure 1B). Both feet presented laterally set
fifth toes. Laboratory investigations for metabolic dis-
orders (ammonium, lactic acid, creatine kinase, aminoa-
cids in serum and urine, organic acids and creatine/
guanidinoacetate in urine, isoelectric focusing of serum
transferrin) were normal. Ophthalmologic evaluation,
electroencephalogram and auditory evoked potentials
were also normal. Brain MRI performed at five years five
months of age revealed reduction of the volume and
thickness of the isthmus and of the splenium of the cor-
pus callosum with a dysmorphic aspect of the rostrum.
No lesions of the supratentorial tissues were identified.
Both cerebellar hemispheric and vermian folia, in the
subtentorial regions, were wilted without signal alter-
ation (Figure 2). A control MRI after one year confirmed
the presence of non-progressive neuroradiologic features
characterized by posterior corpus callosum hypoplasia
and mild cerebellar hypoplasia. Molecular analysis for
Fragile-X syndrome was negative. The mother was not
available for clinical evaluation or MRI screening but
consented to cytogenetic analysis.
Cytogenetic, Fluorescence in situ hybridization and
array-CGH analyses
Cytogenetic analysis was performed using GTG-banding
techniques on metaphase chromosomes obtained by
standard procedures from peripheral blood lymphocytes.
FISH analyses, according to standard protocols, were
carried out using BlueFISH BAC probes (http://www.
cambridgebluegnome.com/bluefish) RP11-294J5 and RP11-
100F18 mapping to 17p13.3 at the positions chr17:1,
199,461-1,352,559 and chr17:1,314,902-1,514,082 (build
37.1, Feb 2009), respectively. Array-CGH was addition-
ally performed on the proband and other family mem-
bers using the Agilent Human Genome CGH Microarray
Kit G3 400K (Agilent Technologies, Santa Clara, CA,
USA) platform, according to the manufacturer’s instruc-
tions. This high resolution 60-mer oligonucleotide-based
microarray spans coding and non coding genomic
sequences with a median spacing of 5.3 kb. Data analysis
was performed using the Agilent Genomic Workbench
Lite Edition Software 6.5.0.18(2) with the following set-
tings for CGH aberration calling: ADM-2 algorithm
(threshold 5) with a moving average of 500 KB and visual
inspection of the log2 ratios. DNA sequence information
was according to the UCSC Genome Browser (http://
genome.ucsc.edu/; GRCh37/hg19, February 2009).
Figure 1 A) Family tree that shows the individuals who were available for array-CGH. Some components of the family were reported as
being affected by behavioural deficits. Arrow indicates the affected child. Full symbols indicate the individuals carrying the 17p13.3 duplication.
NA indicates the individuals not available for array-CGH. B) Photographs of face and hands of the child carrying the 17p13.3 duplication. Mild
facial anomalies such as thickened eyebrows, upslanting eyes, squared nasal tip, large and low-set ears. Short and stubby hands with low-set
thumbs. The step mother gave consent to publish the photoghaphs of the child.
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The patient and his mother had a normal G-band karyo-
type. The array CGH analysis revealed a 17p13.3 dupli-
cation of ~329.5 Kb between oligomers at 1,122,235Mb
(A_18_P12560163, first duplicated) and 1,451,751Mb
(A_16_P20564512, last duplicated), flanked by oligomers
at 1,117,136Mb (A_16_P20563792, first present) and1,455,928Mb (A_16_P03201459, last present), in the
patient and his mother, while his maternal grandmother
and his maternal uncle had normal array-CGH analysis
(Figure 3A). FISH studies with BACs RP11-294J5 and
RP11-100F18 excluded a more complex rearrangement
and the insertion of the duplicated segment in another
chromosome. The duplicated region contains only seven
Figure 2 MR imaging. A) sagittal turbo-field-echo T1-weighted image shows hypoplastic callosal splenium (arrows). B) coronal fast spin-echo
T2-weighted image shows slightly prominent cerebellar fissures (arrows), consistent with a mild form of cerebellar hypoplasia.
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a9), TUSC5 (tumor suppressor candidate 5), YWHAE
(tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein, epsilon polipeptide), CRK (v-crk avian sar-
coma virus CT10 oncogene homolog),MYO1C (MYOSIN 2),
INPP5K (inositol polyphosphate 5-phosphatase K), PITPNA
(phosphatidylinositol transfer protein alpha isoform) (in-
tron 9) (Figure 3B).Figure 3 A) Result of array-CGH analysis of chromosome 17 with Agil
duplicated region extends between probes A_18_P12560163 (1,122,235Mb
duplicated region.Discussion
The use of array-CGH analyses for investigation of
children with mental retardation has led to the identifi-
cation of a growing number of new microdeletion and
microduplication syndromes, some of which have been
clinically well characterised while some other await fur-
ther delineation.ent Human Genome CGH microarray Kit G3 400K. The 17p13.3
) and A_16_P20564512 (1,451,751Mb). B) Gene contents of the
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larly prone to cryptic rearrangements for the presence of
a high density of low copy repeats. The Miller-Dieker
syndrome (MDS) is localized in the more distal region
17p13.3 containing the PAFAH1B1 (encoding LIS1) and
YWHAE genes. Recently, novel co-locating microdele-
tions and microduplications in chromosome 17p13.3
were identified by array-CGH describing new genomic
disorders in the MDS locus. Most of these rearrange-
ments are non-recurring and vary in size, from one hun-
dred kilobases to about three megabases. The clinical
characterization of both microdeletions and microdupli-
cations has been dissected according to the extension
and the genes involved in such rearrangements. The
main characteristics of 17p13.3 microdeletion are signifi-
cant postnatal growth retardation, mild to moderate
mental retardation, and facial anomalies.
Our patient and his mother have an interstitial micro-
duplication of about 329.5 Kbs containing only seven
genes. Many other patients with microduplications of
varying size have been reported with different break-
points and gene content [5,7,9]. Bruno et al.[5] reported
on two cases (cases 9 and 11) in which duplicated
regions overlapped the one reported here, containing
CRK, YWHAE, and BHLA9 genes. Only the duplication
described by Bi et al., [9] (subject 2) is superimposableFigure 4 Schematic representation of five 17p13.3 duplications in rel
17. For each individual, the solid lines (grey shading) below the map repre
according to UCSC Genome Browser Build 36.1 2009 (nucleotide positions
Hg18; nucleotide position of Bi case 1 was deduced (not indicated in the r
for 17p13.3 microduplications in the five cases.on that described here, while the duplicated region of
subject 1 spans 240 Kb and contains only four genes:
TUSC5, YWHAE, CRK, and MYO1C (Figure 4). Among
the genes comprised in the duplicated region, particular
interest has been paid to YWHAE. YWHAE is a gene en-
coding 14-3-3epsilon, which is highly conserved across
species, from bacteria to humans, and binds to phospho-
serine/phosphothreonine motifs in a sequence-specific
manner. The individuals with duplications including
YWHAE are characterized by a milder neurocognitive
and pervasive developmental disorder phenotype, and
share some minor craniofacial abnormalities [9]. The
main phenotypic features of the patients include autistic
manifestations, behavioral symptoms, developmental
delay, varying degree of mental retardation, speech delay,
several common facial features, and subtle hand/foot
malformations. Three families were reported [10] with
split-hand/foot malformation and long bone deficiency
(SHFLD); the same authors suggested that a locus
responsible for this condition is located within a dupli-
cated segment on 17p13.3 band containing ABR and
BHLHA9 genes. In another study, seventeen patients
with 17p13.3 duplication, among 56 families with
SHFLD syndrome, showed a minimal critical region
encompassing the BHLHA9 gene [11]. Therefore, the
authors concluded that the 17p duplication could beation to gene content. Enlargement of band p13.3 of chromosome
sent duplicated regions and nucleotide positions are indicated
of Bi cases 1 and 2 and Bruno cases 9 and 11 were converted from
eport). The dotted lines restrict the minimal critical region of overlap
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necessary but not sufficient for the development of these
malformations. The high degree of non-penetrance could
be dependent on other modifiers not identified yet.
Bruno et al. [5] suggested that there are two classes of
co-locating microduplications on 17p13.3. Class I dupli-
cations involve YWHAE, but not PAFAH1B1 and the
patients show autistic manifestation and behavioral pro-
blems, speech and motor delay, mild dysmorphic facial
features, subtle hand and foot anomalies, and tendency
to overgrowth. Class II microduplications always involve
PAFAH1B1 and may extend to CRK and YWHAE and
have been associated to hypotonia, mild developmental,Table 1 Phenotypic features of patient with 17p13.3. class I m
Index case Bi et al., subject 1
Age 8 years 6 years
Gender M M
Gestational age (weeks) 37 NA
Birth weight (g) 3350 3900
Birth length (cm) NA NA
Birth head circumference (cm) NA NA
Postnatal growth retardation - -
Overgrowth + (75th centile) + (90th centile)
Feeding difficulties - -
Muscle hypotonia + +
Delay in motor function + +
Cognitive development Global delay Mild to moderate
global delay
Speech delay ++ ++
Neurobehavioural symptoms PDD-NOS Behavior problems,
aggressive tendencie














Mouth Thin Thin upper lip
Mandible Pointed chin NA









NA not available, N normal, PDD-NOS pervasive developmental disorder not otherwand psychomotor delay. Some dysmorphic features as
prominent forehead and pointed chin, sometimes asso-
ciated with microcephaly and growth restriction, are the
most common characteristics [5]. Our patient is tall with
mild facial anomalies like upslanting eyes, squared nasal
tip, normal chin, large and low-set ears, short hands with
low-set thumbs, while the feet had laterally set fifth toes.
Moderate mental retardation was associated with a per-
vasive developmental disorder not otherwise specified
(PDD-NOS) with social interactions and communication
impairment, motor stereotypes, perseveration behaviours,
and attention deficit. Brain MRI identified the presence of
non-progressive neuroradiological features characterizedicroduplication
Bi et al., subject 2 Bruno et al., case 9 Bruno et al., case 11
8 years 2 years 14 years
F M M
At term At term At term
4592 3400 3487
57 51 N
NA NA 50th centile
- - -
+3 SD - + (90-97th centile)
- - +
+ - +
+ Delay in fine
motor skills
+











N Broad, sparse eyebrows
g Squared N Squared, upturned tip
Large Prominent Large, fleshy
Thin upper lip Prominent cupid
bow
Prominent cupid bow
Prominent chin Pointed chin Pointed chin






- - Genu valgum
Thin corpus callosum NP NP
ise specified, NP not performed.
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bellar hypoplasia. According to the identified duplication
involving YWHAE, but not PAFAH1B1, our patient could
fit as having a class I duplication. Furthermore, his clinical
phenotype seems to overlap the features previously identi-
fied in such patients, as showed in Table 1.
However, in the patient’s family history we have to
consider that his mother presented antisocial behaviour,
bipolar disorder, and alcoholism, but unfortunately she
was not available for clinical evaluation or MRI tests.
Furthermore, his father was drug addicted and his
grandmother was affected by depression. Several envir-
onmental problems, intertwining with genetic factors,
affect this family. Although genetic and environmental
influences may work independently, research is begin-
ning to acknowledge that these factors work in concert
to influence the behavioral phenotype, as depression and
anxiety [12]. We should therefore consider the 17p13.3
duplication in terms of genetic contribution to a pheno-
type that, especially in his mother, seems to be due to
different components.
Conclusions
In conclusion, our report contributes to a better defin-
ition of the minimal critical region for class 1 micro-
duplications including BHLHA9, YWHAE, and CRK.
Additional patients will be necessary to further substan-
tiate the significance of 17p13.3 microduplications and
to establish a better genotype-phenotype correlation.
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